Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Pneumaturia and Nephrotic Syndrome Caused by a HiddenPelvic Malignancy.

Li W, Sanders B, Tolwani A.

Am J Med. 2018 Oct;131(10):e421-e422. doi: 10.1016/j.amjmed.2018.05.030. Epub 2018 Jun 18. No abstract available.

PMID:
29913123
2.

A Monte Carlo Simulation Approach for Beta-Lactam Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.

Jang SM, Gharibian KN, Lewis SJ, Fissell WH, Tolwani AJ, Mueller BA.

J Clin Pharmacol. 2018 Oct;58(10):1254-1265. doi: 10.1002/jcph.1137. Epub 2018 May 10.

PMID:
29746711
3.

Timing of Renal Replacement Therapy for Acute Kidney Injury.

Karakala N, Tolwani AJ.

J Intensive Care Med. 2019 Feb;34(2):94-103. doi: 10.1177/0885066618774257. Epub 2018 May 8.

PMID:
29739260
4.

Challenges of performing renal replacement therapy in the intensive care unit - The nephrologist perspective.

Cerdá J, Tolwani A, Palevsky P.

Clin Nephrol. 2018 Jul;90(1):11-17. doi: 10.5414/CN109243. No abstract available.

PMID:
29633701
5.

Renal replacement therapy intensity for acute kidney injury and recovery to dialysis independence: a systematic review and individual patient data meta-analysis.

Wang Y, Gallagher M, Li Q, Lo S, Cass A, Finfer S, Myburgh J, Bouman C, Faulhaber-Walter R, Kellum JA, Palevsky PM, Ronco C, Saudan P, Tolwani A, Bellomo R.

Nephrol Dial Transplant. 2018 Jun 1;33(6):1017-1024. doi: 10.1093/ndt/gfx308.

PMID:
29186517
6.

Managing Issues in Dialysis for the Patient with AKI.

Judd E, Tolwani A.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1538-1542. doi: 10.2215/CJN.02270217. Epub 2017 Jun 21. No abstract available.

7.

Current state of the art for renal replacement therapy in critically ill patients with acute kidney injury.

Bagshaw SM, Darmon M, Ostermann M, Finkelstein FO, Wald R, Tolwani AJ, Goldstein SL, Gattas DJ, Uchino S, Hoste EA, Gaudry S.

Intensive Care Med. 2017 Jun;43(6):841-854. doi: 10.1007/s00134-017-4762-8. Epub 2017 Mar 13. Review.

PMID:
28289816
8.

Precision Continuous Renal Replacement Therapy and Solute Control.

Bagshaw SM, Chakravarthi MR, Ricci Z, Tolwani A, Neri M, De Rosa S, Kellum JA, Ronco C; ADQI Consensus Group.

Blood Purif. 2016;42(3):238-47. doi: 10.1159/000448507. Epub 2016 Aug 26.

9.

Pharmacokinetics and Pharmacodynamics of Extended Infusion Versus Short Infusion Piperacillin-Tazobactam in Critically Ill Patients Undergoing CRRT.

Shotwell MS, Nesbitt R, Madonia PN, Gould ER, Connor MJ, Salem C, Aduroja OA, Amde M, Groszek JJ, Wei P, Taylor ME, Tolwani AJ, Fissell WH.

Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1377-83. doi: 10.2215/CJN.10260915. Epub 2016 May 19.

10.

We Use Heparin as the Anticoagulant for CRRT.

Karakala N, Tolwani A.

Semin Dial. 2016 Jul;29(4):272-4. doi: 10.1111/sdi.12503. Epub 2016 Apr 15.

PMID:
27082940
11.

A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury.

Tumlin JA, Galphin CM, Tolwani AJ, Chan MR, Vijayan A, Finkel K, Szamosfalvi B, Dev D, DaSilva JR, Astor BC, Yevzlin AS, Humes HD; SCD Investigator Group.

PLoS One. 2015 Aug 5;10(8):e0132482. doi: 10.1371/journal.pone.0132482. eCollection 2015.

12.

A Prospective International Multicenter Study of AKI in the Intensive Care Unit.

Bouchard J, Acharya A, Cerda J, Maccariello ER, Madarasu RC, Tolwani AJ, Liang X, Fu P, Liu ZH, Mehta RL.

Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1324-31. doi: 10.2215/CJN.04360514. Epub 2015 Jul 20.

13.

Levels of protein C and soluble thrombomodulin in critically ill patients with acute kidney injury: a multicenter prospective observational study.

Bouchard J, Malhotra R, Shah S, Kao YT, Vaida F, Gupta A, Berg DT, Grinnell BW, Stofan B, Tolwani AJ, Mehta RL.

PLoS One. 2015 Mar 19;10(3):e0120770. doi: 10.1371/journal.pone.0120770. eCollection 2015.

14.

Assessing continuous renal replacement therapy as a rescue strategy in cardiorenal syndrome 1.

Prins KW, Wille KM, Tallaj JA, Tolwani AJ.

Clin Kidney J. 2015 Feb;8(1):87-92. doi: 10.1093/ckj/sfu123. Epub 2014 Nov 17.

15.

A continuous veno-venous hemofiltration protocol with anticoagulant citrate dextrose formula A and a calcium-containing replacement fluid.

Ong SC, Wille KM, Speer R, Tolwani AJ.

Int J Artif Organs. 2014 Jun;37(6):499-502. doi: 10.5301/ijao.5000323. Epub 2014 Apr 15.

PMID:
24811309
16.

A patient with AKI after cardiac surgery.

Tolwani AJ.

Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1470-8. doi: 10.2215/CJN.10461013. Epub 2014 Mar 20.

17.

Efficacy and safety of 5 anesthetics in adult zebrafish (Danio rerio).

Collymore C, Tolwani A, Lieggi C, Rasmussen S.

J Am Assoc Lab Anim Sci. 2014 Mar;53(2):198-203.

18.

Association between renal replacement therapy in critically ill patients with severe acute kidney injury and mortality.

Bagshaw SM, Uchino S, Kellum JA, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Bellomo R; Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators.

J Crit Care. 2013 Dec;28(6):1011-8. doi: 10.1016/j.jcrc.2013.08.002. Epub 2013 Sep 24.

PMID:
24075302
19.

Continuous renal-replacement therapy for acute kidney injury.

Tolwani A.

N Engl J Med. 2013 Mar 21;368(12):1160-1. doi: 10.1056/NEJMc1301071. No abstract available.

PMID:
23514300
20.

KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury.

Palevsky PM, Liu KD, Brophy PD, Chawla LS, Parikh CR, Thakar CV, Tolwani AJ, Waikar SS, Weisbord SD.

Am J Kidney Dis. 2013 May;61(5):649-72. doi: 10.1053/j.ajkd.2013.02.349. Epub 2013 Mar 15. Review.

PMID:
23499048
21.

Continuous renal-replacement therapy for acute kidney injury.

Tolwani A.

N Engl J Med. 2012 Dec 27;367(26):2505-14. doi: 10.1056/NEJMct1206045. Review. No abstract available.

PMID:
23268665
22.

The effect of the selective cytopheretic device on acute kidney injury outcomes in the intensive care unit: a multicenter pilot study.

Tumlin JA, Chawla L, Tolwani AJ, Mehta R, Dillon J, Finkel KW, DaSilva JR, Astor BC, Yevzlin AS, Humes HD.

Semin Dial. 2013 Sep-Oct;26(5):616-23. doi: 10.1111/sdi.12032. Epub 2012 Oct 29.

PMID:
23106607
23.

Advances in continuous renal replacement therapy: citrate anticoagulation update.

Tolwani A, Wille KM.

Blood Purif. 2012;34(2):88-93. doi: 10.1159/000342378. Epub 2012 Oct 24. Review.

PMID:
23095407
24.

Regional citrate anticoagulation for continuous renal replacement therapy: the better alternative?

Tolwani A, Wille KM.

Am J Kidney Dis. 2012 Jun;59(6):745-7. doi: 10.1053/j.ajkd.2012.03.003. No abstract available.

PMID:
22613393
25.

Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.

Nadim MK, Kellum JA, Davenport A, Wong F, Davis C, Pannu N, Tolwani A, Bellomo R, Genyk YS; ADQI Workgroup.

Crit Care. 2012 Feb 9;16(1):R23. doi: 10.1186/cc11188. Review.

26.

Pharmacokinetics and pharmacodynamics of piperacillin-tazobactam in 42 patients treated with concomitant CRRT.

Bauer SR, Salem C, Connor MJ Jr, Groszek J, Taylor ME, Wei P, Tolwani AJ, Fissell WH.

Clin J Am Soc Nephrol. 2012 Mar;7(3):452-7. doi: 10.2215/CJN.10741011. Epub 2012 Jan 26.

27.

Solute clearance in CRRT: prescribed dose versus actual delivered dose.

Lyndon WD, Wille KM, Tolwani AJ.

Nephrol Dial Transplant. 2012 Mar;27(3):952-6. doi: 10.1093/ndt/gfr480. Epub 2011 Sep 5.

28.

Critical care nephrology: management of acid-base disorders with CRRT.

Cerdá J, Tolwani AJ, Warnock DG.

Kidney Int. 2012 Jul;82(1):9-18. doi: 10.1038/ki.2011.243. Epub 2011 Aug 3. Review.

29.

Renal kallikrein excretion and epigenetics in human acute kidney injury: expression, mechanisms and consequences.

Kang SW, Shih PA, Mathew RO, Mahata M, Biswas N, Rao F, Yan L, Bouchard J, Malhotra R, Tolwani A, Khandrika S, Mehta RL, O'Connor DT.

BMC Nephrol. 2011 Jun 16;12:27. doi: 10.1186/1471-2369-12-27.

30.

Renal replacement therapy in special settings: extracorporeal support devices in liver failure.

Cerdá J, Tolwani A, Gibney N, Tiranathanagul K.

Semin Dial. 2011 Mar-Apr;24(2):197-202. doi: 10.1111/j.1525-139X.2011.00827.x. Review. Erratum in: Semin Dial. 2011 Jul-Aug;24(4):468.

PMID:
21517988
31.

Management of complications in renal replacement therapy.

Shingarev R, Wille K, Tolwani A.

Semin Dial. 2011 Mar-Apr;24(2):164-8. doi: 10.1111/j.1525-139X.2011.00828.x.

PMID:
21517982
32.

Development, implementation, and results of the ASN in-training examination for fellows.

Rosner MH, Berns JS, Parker M, Tolwani A, Bailey J, DiGiovanni S, Lederer E, Norby S, Plumb TJ, Qian Q, Yeun J, Hawley JL, Owens S; ASN In-Training Examination Committee.

Clin J Am Soc Nephrol. 2010 Feb;5(2):328-34. doi: 10.2215/CJN.06860909. Epub 2009 Dec 3.

33.
34.

Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study.

Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Straaten HO, Ronco C, Kellum JA.

Crit Care Med. 2009 Sep;37(9):2576-82. doi: 10.1097/CCM.0b013e3181a38241.

PMID:
19623048
35.

Anticoagulation for continuous renal replacement therapy.

Tolwani AJ, Wille KM.

Semin Dial. 2009 Mar-Apr;22(2):141-5. doi: 10.1111/j.1525-139X.2008.00545.x. Review.

PMID:
19426417
36.

Introduction. The clinical application of CRRT--current status.

Tolwani AJ, Palevsky PM.

Semin Dial. 2009 Mar-Apr;22(2):107. doi: 10.1111/j.1525-139X.2008.00557.x. No abstract available.

PMID:
19426411
37.

A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury.

Bagshaw SM, Uchino S, Cruz D, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Kellum JA; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators.

Nephrol Dial Transplant. 2009 Sep;24(9):2739-44. doi: 10.1093/ndt/gfp159. Epub 2009 Apr 6.

PMID:
19349297
38.

Outcomes of critically ill children requiring continuous renal replacement therapy.

Hayes LW, Oster RA, Tofil NM, Tolwani AJ.

J Crit Care. 2009 Sep;24(3):394-400. doi: 10.1016/j.jcrc.2008.12.017. Epub 2009 Mar 27.

PMID:
19327959
39.

Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury.

Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Kellum JA; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators.

J Crit Care. 2009 Mar;24(1):129-40. doi: 10.1016/j.jcrc.2007.12.017. Epub 2008 Apr 18.

PMID:
19272549
40.

The epidemiology of severe acute kidney injury: from BEST to PICARD, in acute kidney injury: new concepts.

Pisoni R, Wille KM, Tolwani AJ.

Nephron Clin Pract. 2008;109(4):c188-91. doi: 10.1159/000142927. Epub 2008 Sep 18. Review.

PMID:
18802366
41.

Standard versus high-dose CVVHDF for ICU-related acute renal failure.

Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM.

J Am Soc Nephrol. 2008 Jun;19(6):1233-8. doi: 10.1681/ASN.2007111173. Epub 2008 Mar 12.

42.

Treatment of patients with cardiac surgery associated-acute kidney injury.

Tolwani A, Paganini E, Joannidis M, Zamperetti N, Verbine A, Vidyasagar V, Clark W, Ronco C.

Int J Artif Organs. 2008 Feb;31(2):190-6.

PMID:
18311735
43.

Efficacy and safety of renal tubule cell therapy for acute renal failure.

Tumlin J, Wali R, Williams W, Murray P, Tolwani AJ, Vinnikova AK, Szerlip HM, Ye J, Paganini EP, Dworkin L, Finkel KW, Kraus MA, Humes HD.

J Am Soc Nephrol. 2008 May;19(5):1034-40. doi: 10.1681/ASN.2007080895. Epub 2008 Feb 13.

44.

Delivery of renal replacement therapy in acute kidney injury: what are the key issues?

Davenport A, Bouman C, Kirpalani A, Skippen P, Tolwani A, Mehta RL, Palevsky PM.

Clin J Am Soc Nephrol. 2008 May;3(3):869-75. doi: 10.2215/CJN.04821107. Epub 2008 Jan 30.

45.

A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance.

Tolwani AJ, Prendergast MB, Speer RR, Stofan BS, Wille KM.

Clin J Am Soc Nephrol. 2006 Jan;1(1):79-87. Epub 2005 Nov 23.

46.

Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes.

Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Kellum JA; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators.

Clin J Am Soc Nephrol. 2007 May;2(3):431-9. Epub 2007 Mar 21.

47.

Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators.

Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten H, Ronco C, Kellum JA.

Intensive Care Med. 2007 Sep;33(9):1563-70. Epub 2007 Jun 27.

PMID:
17594074
48.

Patient and kidney survival by dialysis modality in critically ill patients with acute kidney injury.

Uchino S, Bellomo R, Kellum JA, Morimatsu H, Morgera S, Schetz MR, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-Van Straaten HM, Ronco C; Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators Writing Committee.

Int J Artif Organs. 2007 Apr;30(4):281-92.

PMID:
17520564
49.

Sustained low-efficiency dialysis.

Tolwani AJ, Wheeler TS, Wille KM.

Contrib Nephrol. 2007;156:320-4. Review.

PMID:
17464142
50.

Citrate-based replacement solutions with continuous venovenous hemofiltration: not as simple as it sounds.

Tolwani A, Wille KM.

Am J Kidney Dis. 2006 Jun;47(6):1086; author reply 1086-7. No abstract available.

PMID:
16731311

Supplemental Content

Loading ...
Support Center